Article ; Online: Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of
2021 Volume 15, Issue 6, Page(s) 799–810
Abstract: Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used ... ...
Abstract | Vonoprazan (VPZ), a new potassium-competitive acid blocker, has been approved and used for |
---|---|
MeSH term(s) | Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Clarithromycin/therapeutic use ; Drug Therapy, Combination ; Helicobacter Infections/drug therapy ; Helicobacter pylori ; Humans ; Metronidazole/therapeutic use ; Potassium/therapeutic use ; Proton Pump Inhibitors/therapeutic use ; Treatment Outcome |
Chemical Substances | Anti-Bacterial Agents ; Proton Pump Inhibitors ; Metronidazole (140QMO216E) ; Amoxicillin (804826J2HU) ; Clarithromycin (H1250JIK0A) ; Potassium (RWP5GA015D) |
Language | English |
Publishing date | 2021-04-13 |
Publishing country | Korea (South) |
Document type | Journal Article ; Review |
ZDB-ID | 2399010-7 |
ISSN | 2005-1212 ; 1976-2283 |
ISSN (online) | 2005-1212 |
ISSN | 1976-2283 |
DOI | 10.5009/gnl20242 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6610: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.